Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4562804
Max Phase: Preclinical
Molecular Formula: C40H49F2N7O9
Molecular Weight: 809.87
Molecule Type: Unknown
Associated Items:
ID: ALA4562804
Max Phase: Preclinical
Molecular Formula: C40H49F2N7O9
Molecular Weight: 809.87
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1ccc(NC(=O)N[C@@H](Cc2cc(F)cc(F)c2)C(=O)N[C@@H]2C(=O)N3CCC[C@H]3C(=O)N3CCOC[C@H]3C(=O)N[C@@H](C)C(=O)N3C[C@H](C)C[C@H]3C(=O)O[C@H]2C)cc1
Standard InChI: InChI=1S/C40H49F2N7O9/c1-21-7-9-28(10-8-21)44-40(56)45-29(17-25-15-26(41)18-27(42)16-25)34(50)46-33-24(4)58-39(55)31-14-22(2)19-49(31)36(52)23(3)43-35(51)32-20-57-13-12-48(32)37(53)30-6-5-11-47(30)38(33)54/h7-10,15-16,18,22-24,29-33H,5-6,11-14,17,19-20H2,1-4H3,(H,43,51)(H,46,50)(H2,44,45,56)/t22-,23+,24+,29+,30+,31+,32+,33+/m1/s1
Standard InChI Key: ILLIISVMWUDHLV-MDCZBRCISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 809.87 | Molecular Weight (Monoisotopic): 809.3560 | AlogP: 1.40 | #Rotatable Bonds: 6 |
Polar Surface Area: 195.79 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 16 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 11.02 | CX Basic pKa: | CX LogP: 1.51 | CX LogD: 1.51 |
Aromatic Rings: 2 | Heavy Atoms: 58 | QED Weighted: 0.31 | Np Likeness Score: -0.12 |
1. (2018) Substituted urea depsipeptide analogs as activators of the clpp endopeptidase, |
Source(1):